Trials / Completed
CompletedNCT01375725
Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
Mobius PT-INR Accuracy Clinical Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Universal Biosensors Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2011-06-17
- Last updated
- 2011-06-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01375725. Inclusion in this directory is not an endorsement.